# Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer

> **NCT02137746** · PHASE2 · COMPLETED · sponsor: **SOTIO a.s.** · enrollment: 24 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Dendritic Cells DCVAC/PCa

## Key facts

- **NCT ID:** NCT02137746
- **Lead sponsor:** SOTIO a.s.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-04
- **Final completion:** 2017-03-20
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137746, "Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02137746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*